Skip to content
Forest Global Training Partners
Home Services AI Governance AI Risk Encyclopedia Contact Us
AI Risk Encyclopedia AI Use CasesAI RisksAI Hallucinations Topics Entities Sources
  1. Home
  2. AI Risks
  3. FDA's Generative AI Discussion Paper Signals a Break from…

AI Risks September 02, 2026 · akingump.com

FDA's Generative AI Discussion Paper Signals a Break from the Past in Terminology, But ...

... risks ” of medical devices enabled by GenAI. While FDA has previously recognized this dynamic for artificial intelligence ( AI ) generally, this ...

Read the original at akingump.com ↗

Topics
HealthcareChatbots & LLMs
Mentions
FDA
Tracked via
“AI Risks”

Related articles

  • New WHO discussion paper sets out opportunities and risks of AI in evidence-informed health policy AI Risks · Jun 02, 2026
  • Law Commission publishes discussion paper on AI legal challenges - PPC Land AI Risks · Aug 10, 2025
  • Examining The FDA's Recommendations ForAI-Enabled Medical Devices - Forbes AI Risks · Mar 03, 2025
  • Research shows even average users can break past AI safety within Gemini and ChatGPT AI Risks · Nov 06, 2025
  • AdvaMed Encourages Risk -Based FDA Approach to Generative AI Medical Devices AI Risks · Oct 27, 2026
  • FDA to hopeful marketers ofAI-equipped medical devices: Think beyond your initial approval AI Risks · Jan 07, 2025

AI Risk Encyclopedia is a curated research index from Forest Global Training Partners. Articles belong to their publishers; we link to and summarize them.

Contact